Hormonal
Roux-en-Y gastric bypass (RYGB) resolves type 2 diabetes mellitus in approximately 83% of cases, often within days of surgery, through mechanisms that improve insulin sensitivity and secretion independently of immediate weight loss.
If you have type 2 diabetes and undergo Roux-en-Y gastric bypass, expect a high likelihood of remission (approx. 83%), often occurring within days of surgery, long before you lose significant weight. This is driven by hormonal changes that improve insulin sensitivity and secretion. You may be able to discontinue diabetes medications quickly, but this requires close medical supervision.
In five published studies examining a total of 3568 people undergoing RYGB, diabetic patients enjoyed complete remission of their disease at rates ranging from 82–98%, with most studies showing resolution in approximately 83% of cases... previously diabetic patients typically discontinue all of their DM medications at the time of discharge from the hospital after RYGB (~1 wk), long before major weight loss has occurred.
Why this rating
Based on multiple published studies with large sample sizes (total 3568 people) and consistent findings of high remission rates.
Source
Gastric Bypass for Obesity: Mechanisms of Weight Loss and Diabetes Resolution
David E. Cummings et al. · The Journal of Clinical Endocrinology & Metabolism · 2004
DOI 10.1210/jc.2004-0433
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →